Article
Dermatologists aren't the only ones who see the virtues of Accutane (isotretinoin).
Reflecting on the Growth of NPs and PAs in Dermatology
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Bridging Therapeutic Innovation and Dermatology
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Nektar Therapeutics Completes Enrollment for Phase 2b REZOLVE-AD Trial of Rezpegaldesleukin
Study Reveals Immune Checkpoint Inhibitor Treatment and Monitoring Practices Post-Remission